126 related articles for article (PubMed ID: 9640223)
21. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
[TBL] [Abstract][Full Text] [Related]
22. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia.
Breymann C; Zimmermann R; Huch R; Huch A
Eur J Clin Invest; 1996 Feb; 26(2):123-30. PubMed ID: 8904521
[TBL] [Abstract][Full Text] [Related]
23. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
24. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
Charuruks N; Voravud N; Limpanasithikul W
J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog.
Koumegawa J; Kawahara J; Kubo K; Amano K; Wakimoto N; Takahashi K; Juji T; Takaku F
Int J Cell Cloning; 1990 Mar; 8(2):97-106. PubMed ID: 2313141
[TBL] [Abstract][Full Text] [Related]
27. rhEPO treatment of postpartum anemia.
Zimmermann R; Breymann C; Richter C; Huch R; Huch A
J Perinat Med; 1995; 23(1-2):111-7. PubMed ID: 7658310
[TBL] [Abstract][Full Text] [Related]
28. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
[TBL] [Abstract][Full Text] [Related]
29. Management of chemotherapy-induced anemia.
Eguchi K
Curr Opin Oncol; 1995 Jul; 7(4):316-9. PubMed ID: 7578378
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
Osterborg A; Boogaerts MA; Cimino R; Essers U; Holowiecki J; Juliusson G; Jäger G; Najman A; Peest D
Blood; 1996 Apr; 87(7):2675-82. PubMed ID: 8639883
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis.
Breymann C; Richter C; Hüttner C; Huch R; Huch A
Eur J Clin Invest; 2000 Feb; 30(2):154-61. PubMed ID: 10651841
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study.
Beris P; Mermillod B; Levy G; Laubriat M; Soulier-Lauper M; Tullen E; Hugli A; Miescher PA
Vox Sang; 1993; 65(3):212-8. PubMed ID: 8249364
[TBL] [Abstract][Full Text] [Related]
33. Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
Zarogoulidis K; Papagiannis A; Ziogas E; Fahantidou E; Dermitzakis G; Gioulekas D; Vamvalis C
Eur J Cancer; 1997 Dec; 33(14):2428-31. PubMed ID: 9616293
[TBL] [Abstract][Full Text] [Related]
34. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
Berglund B; Ekblom B
J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
[TBL] [Abstract][Full Text] [Related]
37. A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study.
Di Raimondo F; Longo G; Cacciola E; Milone G; Palumbo GA; Cacciola RR; Alessi M; Giustolisi R
Eur J Haematol; 1996; 56(1-2):7-11. PubMed ID: 8599997
[TBL] [Abstract][Full Text] [Related]
38. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
Matsui H; Shiraishi N; Yasuda T; Nezuka T
Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
[TBL] [Abstract][Full Text] [Related]
39. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
[TBL] [Abstract][Full Text] [Related]
40. Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants.
Bock W; Gröhs B; Minihold B; Schemper M; Lischka A
J Perinat Med; 1995; 23(1-2):133-8. PubMed ID: 7658314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
